CCL28 promotes progression of hepatocellular carcinoma through PDGFD-regulated MMP9 and VEGFA pathways
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Hepatocellular carcinoma (HCC) progression is worsened by increased CCL28 levels. CCL28 promotes HCC cell growth, migration, and invasion via the PDGFD signaling pathway, offering potential therapeutic targets.
Area Of Science
- Oncology
- Molecular Biology
- Immunology
Background
- Hepatocellular carcinoma (HCC) presents significant global health challenges with limited treatment options.
- Chemokines play a crucial role in regulating HCC progression and metastasis.
- Understanding the mechanisms driving HCC is vital for developing effective therapies.
Purpose Of The Study
- To investigate the role of CCL28 in promoting Hepatocellular Carcinoma (HCC) progression.
- To elucidate the molecular mechanisms by which CCL28 influences HCC.
- To identify potential therapeutic targets for HCC treatment based on CCL28's function.
Main Methods
- Bioinformatic analysis and immunohistochemical staining to assess CCL28 expression in HCC.
- Cell proliferation (CCK-8), migration (Transwell), and colony formation assays to evaluate HCC cell behavior.
- Quantitative real-time PCR and Western blotting to explore molecular pathways (PDGFD, MMP9, VEGFA).
Main Results
- Elevated CCL28 levels correlate directly with advanced HCC and poorer patient outcomes.
- CCL28 significantly enhanced HCC cell proliferation, migration, invasion, and clonogenicity.
- CCL28-induced HCC progression was mediated by the activation of PDGFD-regulated MMP9 and VEGFA pathways.
Conclusions
- CCL28 is a key driver of HCC tumorigenesis and progression.
- The PDGFD signaling pathway is implicated in CCL28-mediated HCC development.
- Targeting CCL28 or its downstream pathways presents a promising therapeutic strategy for HCC.
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
Related Concept Videos
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...